Sectors
ANTX
AN2 Therapeutics, Inc.
5.55
2 x 4.02
2 x 6.96
bid
ask
-
0.03
0.54%
2 @ 07:30 PM
5.45 -0.10 (1.80%)
| Ytd | 386.84% | |
| 1y | 404.55% |
5.40
day range
5.64
1.00
52 week range
7.19
| Open | 5.58 | Prev Close | 5.58 | Low | 5.40 | High | 5.64 | Mkt Cap | 209.44M |
| Vol | 124.02K | Avg Vol | 286.27K | EPS | -1.04 | P/E | N/A | Forward P/E | -1.17 |
| Beta | -0.22 | Short Ratio | 0.82 | Inst. Own | 52.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 5.24 | 200-d Avg | 3.27 | 1yr Est | 2.67 |
| Income Statement | |||
| Operating Expenses | 8.90M | ||
| Research and Development Expense | 6.02M | ||
| Selling, General and Administrative Expense | 2.89M | ||
| Operating Income | -8.90M | ||
| Net Income | -8.18M | ||
| Net Income Common Stock | -8.18M | ||
| Net Income Common Stock (USD) | -8.18M | ||
| Consolidated Income | -8.18M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -8.18M | ||
| Earning Before Interest & Taxes (USD) | -8.18M | ||
| Weighted Average Shares | 44.76M | ||
| Weighted Average Shares Diluted | 44.76M | ||
| Balance Sheet | |||
| Cash and Equivalents | 44.32M | ||
| Cash and Equivalents (USD) | 44.32M | ||
| Investments | 35.54M | ||
| Investments Current | 34.07M | ||
| Investments Non-Current | 1.47M | ||
| Current Assets | 79.99M | ||
| Total Assets | 81.68M | ||
| Current Liabilities | 5.59M | ||
| Total Liabilities | 5.76M | ||
| Accumulated Retained Earnings (Deficit) | -259.16M | ||
| Accumulated Other Comprehensive Income | -23.00K | ||
| Shareholders Equity | 75.92M | ||
| Shareholders Equity (USD) | 75.92M | ||
| Assets Non-Current | 1.69M | ||
| Liabilities Non-Current | 170.00K | ||
| Trade and Non-Trade Payables | 1.97M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.49M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.17M | ||
| Issuance (Purchase) of Equity Shares | 1.49M | ||
| Net Cash Flow from Investing | -3.66M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.66M | ||
| Net Cash Flow from Operations | -7.00M | ||
| Share Based Compensation | 972.00K | ||